Non-alcoholic fatty liver disease (NAFLD) causes significant global disease burden and is a
leading cause of mortality. NAFLD induces a myriad of aberrant changes in hepatocytes at …

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease in most
parts of the world affecting one-third of the western population and a growing cause for end …

Abstract Background & Aims Lipotoxicity triggers non-alcoholic fatty liver disease (NAFLD)
progression owing to the accumulation of toxic lipids in hepatocytes including saturated fatty …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease.
Definitive diagnosis of the progressive form, non-alcoholic steatohepatitis (NASH), requires …

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it still remains an orphan of adequate therapies. This …

Sphingolipids are a family of lipid molecules produced through different pathways in
mammals. Sphingolipids are structural components of membranes, but in response to …

The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated
fatty liver disease (MAFLD), as it is now known, has gradually increased. NAFLD is a …

Non-alcoholic steatohepatitis (NASH) has evolved as the most common and devastating
chronic liver disease. This study aimed to explore the underlined mechanism for the …

Non‑alcoholic fatty liver disease (NAFLD) is a widespread threat to human health. However,
the present screening methods for NAFLD are time‑consuming or invasive. The present …

Simple Summary Extracellular vesicles (EVs) are membrane-enclosed vesicles secreted
from most types of cells. EVs encapsulate many diverse bioactive cargoes, such as proteins …